EntryPoint Capital »

Tango Therapeutics shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $153k 20k 7.70

More positions owned by EntryPoint Capital

Strategic Education (STRA)
Harmony Biosciences Hldgs In (HRMY)
Universal Technical Institute (UTI)
Carlyle Group (CG)
Ubiquiti (UI)
Genedx Holdings Corp Com Cl A (WGS)
Tutor Perini Corporation (TPC)
ViaSat (VSAT)
Regal-beloit Corporation (RRX)
Informatica Com Cl A (INFA)
Amgen (AMGN)
United Parcel Service CL B (UPS)
Calix (CALX)
Castle Biosciences (CSTL)
ACI Worldwide (ACIW)

View all positions for EntryPoint Capital

Top funds holding Tango Therapeutics

Trv Gp Iv
TCG Crossover Management
EcoR1 Capital
Boxer Capital Management
Nextech Invest
T. Rowe Price Investment Management
Gilead Sciences
BlackRock
Farallon Capital Management
Vanguard Group
Balyasny Asset Management
Nantahala Capital Management
Bain Capital Life Sciences Investors
Siren
Citadel Advisors

View all funds holding Tango Therapeutics